CLARIANE SE |
Real-time
Other stock markets
|
5-day change | 1st Jan Change | ||
| 1.64 EUR | +1.49% |
|
-2.38% | -31.78% |
| Apr. 05 | CAC40: week ends at half-mast, gold at its zenith | CF |
| Apr. 05 | CAC40: pullback reduced, WStreet +0.7%, Brent at $91, Gold at $233 | CF |
| Sales 2023 | 5.05B 5.39B | Sales 2024 * | 5.3B 5.66B | Capitalization | 173M 184M |
|---|---|---|---|---|---|
| Net income 2023 | -105M -112M | Net income 2024 * | -5M -5.34M | EV / Sales 2023 | 0.05 x |
| Net Debt 2023 * | 7.95B 8.49B | Net Debt 2024 * | 7.55B 8.07B | EV / Sales 2024 * | 1.46 x |
| P/E ratio 2023 * |
7.7
x | P/E ratio 2024 * |
4.55
x | Employees | 56,000 |
| Yield 2023 * |
18.3% | Yield 2024 * |
21% | Free-Float | 62.56% |
More Fundamentals
* Assessed data
More news
Latest transcript on Clariane SE
More press releases
| 1 day | +0.19% | ||
| 1 week | -6.97% | ||
| Current month | +9.63% | ||
| 1 month | +7.45% | ||
| 3 months | -24.63% | ||
| 6 months | -67.87% | ||
| Current year | -32.78% |
1 week
1.56
1.78
1 month
1.321.90
Current year
1.322.68
1 year
1.328.05
3 years
1.3234.76
5 years
1.3245.66
10 years
1.3245.66
| Managers | Title | Age | Since |
|---|---|---|---|
Sophie Boissard
CEO | Chief Executive Officer | 53 | 16-01-25 |
| Director of Finance/CFO | - | 18-03-31 | |
| Chief Tech/Sci/R&D Officer | - | 20-06-30 |
| Members of the board | Title | Age | Since |
|---|---|---|---|
| Director/Board Member | 47 | 21-01-10 | |
Catherine Soubie
BRD | Director/Board Member | 58 | 14-03-17 |
| Chairman | 72 | 16-06-22 |
| Name | Weight | AuM | 1st Jan change | Investor Rating |
|---|---|---|---|---|
| 0.01% | 773 M€ | 0.00% | - | |
| 0.00% | 10 M€ | -3.35% | - |
| Date | Price | Change | Volume |
|---|---|---|---|
| 24-04-18 | 1.64 | +1.49% | 206 453 |
| 24-04-17 | 1.616 | +0.19% | 338,294 |
| 24-04-16 | 1.613 | +0.37% | 241,475 |
| 24-04-15 | 1.607 | -3.19% | 342,676 |
| 24-04-12 | 1.66 | -1.19% | 291,963 |
Real-time Euronext Paris, April 17, 2024 at 11:35 am EDT
More quotes
Clariane SE (formerly Korian) is the European No. 1 private operator of full-care facilities for dependent people. Net sales break down by geographic zone as follows:
- France (49.1%): at the end of 2022, operated 619 facilities (32,974 beds) broken into assisted-living facilities (medical assisted living facilities for the elderly, retirement homes, long-term care facilities and rest homes) and medical facilities (follow-up care and rehabilitation clinics and psychiatric clinics). In addition, the group operates 55 facilities (3,092 beds) in Spain and 11 facilities (727 beds) in the United Kingdom;
- Germany (23.9%): operated 239 facilities (27,392 beds);
- Belgium (14.7%): operated 117 facilities (12,991 beds). Furthermore, the group operates 49 facilities (1,458 beds) in the Netherlands;
- Italy (12.3%): operated 110 facilities (9,360 beds).
Calendar
2024-04-24
- Q1 2024 Sales and Revenue Release
Related indices
Trading Rating
Investor Rating
ESG Refinitiv
B+
Sell
Buy
Mean consensus
HOLD
Number of Analysts
5
Last Close Price
1.616
EUR
Average target price
4.5
EUR
Spread / Average Target
+178.47%
EPS Revisions
Quarterly revenue - Rate of surprise
| 1st Jan change | Capi. | |
|---|---|---|
| -32.78% | 184M | |
| +14.91% | 82.27B | |
| +11.06% | 29.43B | |
| -12.02% | 16.82B | |
| -5.56% | 15.89B | |
| -7.91% | 14.1B | |
| -0.10% | 12.05B | |
| -28.95% | 12.01B | |
| +21.84% | 11.19B | |
| -6.38% | 11.09B |
- Stock Market
- Equities
- CLARI Stock
